Biological Dynamics’ founder and CEO Dr. Raj Krishnan, and Mendelspod podcast host Theral Timpson discuss the evolution of the company’s unique early-stage cancer detection methodology.
Wednesday, March 10 (podcast link)
Biological Dynamics’ founder and CEO Dr. Raj Krishnan, and Mendelspod podcast host Theral Timpson discuss the evolution of the company’s unique early-stage cancer detection methodology.
Wednesday, March 10 (podcast link)
Biological Dynamics is a private molecular diagnostics company located in San Diego. Our proprietary technology offers a novel, fast, and cost-effective lab-on-chip ACE platform that isolates nanoparticles from high conductance physiological solutions.
Our product, the TR(ACE)™ assay, will utilize the platform for monitoring treatment response in oncology. TR(ACE)™ has not been cleared or approved by the U.S. FDA or any foreign regulatory agency.